These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 15476699)

  • 1. Therapeutic potential of adenosine kinase inhibition-Revisited.
    Jarvis MF
    Pharmacol Res Perspect; 2019 Aug; 7(4):e00506. PubMed ID: 31367385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-Iodotubercidin sensitizes cells to RIPK1-dependent necroptosis by interfering with NFκB signaling.
    Chauhan C; Kraemer A; Knapp S; Windheim M; Kotlyarov A; Menon MB; Gaestel M
    Cell Death Discov; 2023 Jul; 9(1):262. PubMed ID: 37495567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Inside Story of Adenosine.
    Camici M; Garcia-Gil M; Tozzi MG
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29522447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effect of Endogenous Adenosine on Neuronal Activity in Rats: An FDG PET Study.
    Parkinson FE; Paul S; Zhang D; Mzengeza S; Ko JH
    J Neuroimaging; 2016 Jul; 26(4):403-5. PubMed ID: 27082948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Adenosine-Mediated Glial-Neuronal Circuit for Homeostatic Sleep.
    Bjorness TE; Dale N; Mettlach G; Sonneborn A; Sahin B; Fienberg AA; Yanagisawa M; Bibb JA; Greene RW
    J Neurosci; 2016 Mar; 36(13):3709-21. PubMed ID: 27030757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine kinase: exploitation for therapeutic gain.
    Boison D
    Pharmacol Rev; 2013 Jul; 65(3):906-43. PubMed ID: 23592612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of sleep and wakefulness.
    Brown RE; Basheer R; McKenna JT; Strecker RE; McCarley RW
    Physiol Rev; 2012 Jul; 92(3):1087-187. PubMed ID: 22811426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine kinase inhibition selectively promotes rodent and porcine islet β-cell replication.
    Annes JP; Ryu JH; Lam K; Carolan PJ; Utz K; Hollister-Lock J; Arvanites AC; Rubin LL; Weir G; Melton DA
    Proc Natl Acad Sci U S A; 2012 Mar; 109(10):3915-20. PubMed ID: 22345561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine and sleep.
    Bjorness TE; Greene RW
    Curr Neuropharmacol; 2009 Sep; 7(3):238-45. PubMed ID: 20190965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sleep disturbances, psychiatric disorders, and psychotropic drugs.
    Staner L
    Dialogues Clin Neurosci; 2005; 7(4):323-34. PubMed ID: 16416708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-inflammatory effects of ABT-702, a novel non-nucleoside adenosine kinase inhibitor, in rat adjuvant arthritis.
    Boyle DL; Kowaluk EA; Jarvis MF; Lee CH; Bhagwat SS; Williams M; Firestein GS
    J Pharmacol Exp Ther; 2001 Feb; 296(2):495-500. PubMed ID: 11160636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of adenosine in sleep in rats.
    Radulovacki M
    Rev Clin Basic Pharm; 1985; 5(3-4):327-39. PubMed ID: 3916307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sleep homeostasis: a role for adenosine in humans?
    Landolt HP
    Biochem Pharmacol; 2008 Jun; 75(11):2070-9. PubMed ID: 18384754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The adenosine kinase inhibitor ABT-702 augments EEG slow waves in rats.
    Radek RJ; Decker MW; Jarvis MF
    Brain Res; 2004 Nov; 1026(1):74-83. PubMed ID: 15476699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABT-702 (4-amino-5-(3-bromophenyl)-7-(6-morpholinopyridin-3-yl)pyrido[2, 3-d]pyrimidine), a novel orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties: I. In vitro characterization and acute antinociceptive effects in the mouse.
    Jarvis MF; Yu H; Kohlhaas K; Alexander K; Lee CH; Jiang M; Bhagwat SS; Williams M; Kowaluk EA
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1156-64. PubMed ID: 11082453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ABT-702 (4-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin- 3-yl)pyrido[2,3-d]pyrimidine), a novel orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties. II. In vivo characterization in the rat.
    Kowaluk EA; Mikusa J; Wismer CT; Zhu CZ; Schweitzer E; Lynch JJ; Lee CH; Jiang M; Bhagwat SS; Gomtsyan A; McKie J; Cox BF; Polakowski J; Reinhart G; Williams M; Jarvis MF
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1165-74. PubMed ID: 11082454
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.